Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Completed · Phase 2/Phase 3

Conditions studied: Head and Neck Cancer, Infection, Oral Complications

In brief

RATIONALE: Giving fluconazole may be effective in preventing or controlling mucositis caused by radiation therapy to the head and neck. PURPOSE: Randomized phase II/III trial to study the effectiveness of fluconazole in preventing mucositis in patients undergoing radiation therapy for head and neck cancer.

Key facts

Study ID

NCT00002533

Run by

University of Miami

Starts

1993-02-01

Expected to finish

2006-08-01

Last updated by the study team

2016-12-15

Who can join

Age: 21 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sylvester Cancer Center, University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.